Term ends Mar 14, 2034 · Low confidence
20-year base term ends Mar 14, 2034
Grace period ended Nov 6, 2026 · no payment on record as of the Nov 17, 2026 fee file · lapse expected
Held by Epizyme, Inc.
Filed Dec 8, 2017 as application 15/835,758 · Granted Nov 6, 2018
Base term, 20 years from filing
Today
2014
2034
Clock starts
Mar 14, 2014
Mar 14, 2014
Term ends
Mar 14, 2034
Mar 14, 2034
Granted
Nov 6, 2018
Nov 6, 2018
base term
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: Low: the grace period for its second maintenance fee ended Nov 6, 2026 with no payment on record. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 14, 2014, when application PCT/US2014/028463, the earliest non-provisional in its chain, was filed (this one was filed Dec 8, 2017) | Mar 14, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | Read from the payments on the fee record: none for this window, and its grace period has ended. No fee event states a lapse, and USPTO's status still reads "Patented Case". | grace period ended Nov 6, 2026 | Low confidence |
| Computed term end | The steps above, in order | Mar 14, 2034 | Low confidence |
This family
| Application PCT/US2014/028463 | PCT application no patent term | no patent term |
| US 9,738,651 | Lapsed on the fee record Aug 2025 | Aug 2025 |
| US 9,856,267 | Lapsed on the fee record Jan 2026 | Jan 2026 |
| US 10,118,931 | this patent Mar 2034 | Mar 2034 |
| US 10,633,389 | In force Mar 2034 | Mar 2034 |
| US 11,834,455 | In force no later than Oct 2034 | no later than Oct 2034 |
| Application 18/058,549 | Abandoned not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 19, 2018 Reel 47106, frame 597 | Chesworth, Richard; Moradei, Oscar Miguel; Jin, Lei; Shapiro, Gideon; Babine, Robert E. | Epizyme, Inc. | Assignment of Assignor's Interest |
| Nov 19, 2019 Reel 51057, frame 848 | Epizyme, Inc. | Biopharma Credit PLC | Security Interest |
| Aug 13, 2022 Reel 61165, frame 501 | Biopharma Credit PLC | Epizyme, Inc. | Termination and Release of Security Interest in Patents at Reel/Frame: 051057/0848 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 6
Grace period ended Nov 6, 2026 with no payment on record. The term ends early once USPTO posts the lapse
Mar 2034
Term ends Mar 14, 2034.
Citations
20
later US patents cite this one
That is top 25% of utility patents granted in 2018 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.